• Featured Product
  • KD/KO Validated

RBBP9 Monoklonaler Antikörper

RBBP9 Monoklonal Antikörper für

Wirt / Isotyp

Maus / IgG2b

Getestete Reaktivität

human

Anwendung

Konjugation

CoraLite®594 Fluorescent Dye

CloneNo.

3D5E11

Kat-Nr. : CL594-66015

Synonyme

B5T overexpressed gene protein, BOG, Protein BOG, Putative hydrolase RBBP9, RBBP 10, RBBP 9, RBBP10, RBBP9



Geprüfte Anwendungen

Produktinformation

CL594-66015 bindet in RBBP9 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG2b
Klonalität Monoklonal
Typ Antikörper
Immunogen RBBP9 fusion protein Ag17864
Vollständiger Name retinoblastoma binding protein 9
Berechnetes Molekulargewicht 186 aa, 21 kDa
Beobachtetes Molekulargewicht 22 kDa
GenBank-ZugangsnummerBC015938
Gene symbol RBBP9
Gene ID (NCBI) 10741
Konjugation CoraLite®594 Fluorescent Dye
Excitation/Emission maxima wavelengths588 nm / 604 nm
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA
LagerungsbedingungenBei -20°C lagern. Vor Licht schützen. Nach dem Versand ein Jahr stabil. Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

RBBP9, also named as BOG, RBBP10, RBBP-9, RBBP-10 and Protein BOG, belongs to the RBBP9 family. It may play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-β1 through interaction with retinoblastoma and the subsequent displacement of E2F-1. RBBP9 is a tumor-associated serine hydrolase activity required for pancreatic neoplasia. It mediates suppression of TGF-β signaling is required for E-cadherin expression as loss of the serine hydrolase activity leads to a reduction in E-cadherin levels and a concomitant decrease in the integrity of tumor cell-cell junctions..RBBP9 protein levels were equivalent in paired primary tumor and nonneoplastic specimens(PMID:20080647)